Fund HoldingsEuclidean Capital LLC

Total Portfolio Value
$795.85M
Total Bought
$114.40M
Total Sold
$90.50M
Net Transaction
+$23.90M
Filing Period:
Securities
SharesValue ($K)
Q1 2024
Q2 2024
Change
Q1 2024
Q2 2024
Weight (%)
Change
SPDR S&P 500 ETF TR(SPY)974,6411,146,979+172,338509,805624,20978.43%+114,403
ISHARES TR
MSCI INDIA ETF
2,425,1442,425,1440125,113135,27517.00%+10,161
SURROZEN INC170,833170,8330530.00%-2
PMV PHARMACEUTICALS INC2,627,6432,627,64304,4674,2570.53%-210
SURROZEN INC87,69687,69601,3789600.12%-417
23ANDME HOLDING CO10,243,12210,243,12205,4494,0070.50%-1,442
FOGHORN THERAPEUTICS INC1,573,7611,573,761010,5609,0491.14%-1,511
NGM BIOPHARMACEUTICALS INC992,1680-992,1681,5780-1,578
ALECTOR INC1,307,8581,307,85807,8735,9380.75%-1,936
TENAYA THERAPEUTICS INC1,015,7051,015,70505,3123,1490.40%-2,163
RAPT THERAPEUTICS INC657,899657,89905,9082,0070.25%-3,901
ORIC PHARMACEUTICALS INC(ORIC)989,410989,410013,6046,9950.88%-6,609
SPDR GOLD TR(GLD)432,2710-432,27188,9270-88,927
Page 1 of 1